Classes
DEA Class; Rx
Common Brand Names; Viroptic (DSC)
- Antivirals, Ophthalmic
Description
Ophthalmic antiviral preparation with activity against herpes simplex virus (HSV) types 1 and 2, vaccinia virus, and some adenovirus strains; used for primary keratoconjunctivitis and recurrent epithelial keratitis due HSV types 1 and 2; used for epithelial keratitis that has not responded to idoxuridine or vidarabine.
Indications
Indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2
Contraindications
Hypersensitivity
Adverse Effects
- Transient burning/stinging
- Palpebral edema
- Superficial punctate keratopathy
- Epithelial keratopathy
- Stromal edema
- Keratitis sicca
- Hyperemia
- Increased IOP
- Hypersensitivity reactions
Warnings
Cosnider other Tx if no improvement after 7 days or incomplete reepithelialization after 14 days
Use >21 days should be avoided because of potential ocular toxicity
Inactive against bacteria, fungi & Chlamydia
Pregnancy and Lactation
Pregnancy Category: C
Lactation: unlikely to be distributed into breast milk; use caution
Maximum Dosage
9 drops/day to affected eye(s).
9 drops/day to affected eye(s).
9 drops/day to affected eye(s).
> = 6 years: 9 drops/day to affected eye(s).
< 6 years: Safety and efficacy have not been established.
How supplied
Trifluridine
ophthalmic solution
- 1% (generic)
